Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0001104659-24-028888 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-28 | 2024-02-26 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | F - Tax | $29.53 | -10.9K | 604.6K | -2% | -$322.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-26 | F | D | 10,915 | $29.53 | 604,590 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 25,000 restricted stock units on February 26, 2024. |